BSU Seminar: "Causal machine learning for biomarker subgroup discovery in randomised trials".

Add to your list(s) Download to your calendar using vCal

• Paul Newcombe, GlaxoSmithKline
• Tuesday 23 January 2024, 14:00-15:00
• MRC Biostatistics Unit, East Forvie Building, Forvie Site Robinson Way Cambridge CB2 0SR..

If you have a question about this talk, please contact Alison Quenault.

This will be a free hybrid seminar. To register to attend virtually, please click here: https://cam-ac-uk.zoom.us/meeting/register/tZ0rf-qppzwsEtEisA_2ZCkA3KoJ3d53uW1P

Decreasing costs of high-throughput ‘omics, as well as new technologies such as the Olink platform, has driven wider application in clinical trials, for example to inform precision medicine strategies. However, data-driven characterisation of patient subgroups with enhanced (or weaker) treatment effect remains a challenging problem, particularly when searching over high-dimensional biomarkers. With growing recognition that traditional approaches (e.g. exhaustive biomarker-treatment interaction testing) are sub-optimal, several promising methods have recently emerged that combine machine learning tools with concepts from causal inference. In principle, they offer greater power through a combination of less conservative multiplicity control, and the ability to capture complex multivariate signatures which may be missed during one-at-a-time testing.

I will describe three causal machine learning methods for responder subgroup detection; the “Modified covariate Lasso”1, “Causal Forests”2, and the “X-Learner”3. I will compare and assess their performance in a modest simulation study motivated by real biomarker trial datasets being generated in GSK . I will then share some (anonymised) results from on-going application of these methods to detect and predict responder subgroups from transcriptomic data measured in two Phase 3 Lupus trials. Finally, I will close with a discussion on our experience of the benefits and limitations of existing approaches in this space.

This talk is part of the MRC Biostatistics Unit Seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• BHRU Annual Lecture 2015
• BHRU Annual Lecture 2016
• Biology
• Cambridge Centre for Data-Driven Discovery (C2D3)
• Cambridge Immunology
• Cambridge talks
• Cardiovascular Epidemiology Unit Special Seminars
• Chris Davis' list
• Department of Public Health and Primary Care
• Graduate-Seminars
• Interested Talks
• Life Sciences
• Life Sciences
• ME Seminar
• MRC Biostatistics Unit Seminars
• MRC Biostatistics Unit, East Forvie Building, Forvie Site Robinson Way Cambridge CB2 0SR.
• Primary Care
• PublicHealth@Cambridge
• Trust & Technology Initiative - interesting events
• bld31
• my_list
• ndk22's list
• ob366-ai4er
• other talks
• primary care
• rp587

Note that ex-directory lists are not shown.